CHF5074 Reduces Biomarkers of Neuroinflammation in Patients with Mild Cognitive Impairment: A 12-Week, Double-Blind, Placebo- Controlled StudyBruno P. Imbimbo, Gabriella Bottini, M Franceschi et al.|Current Alzheimer Research|2013Cited by 78
Multi-target action of the novel anti-Alzheimer compound CHF5074: in vivo study of long term treatment in Tg2576 miceSandra Sivilia, Luciana Giardino, Laura Calzà et al.|BMC Neuroscience|2013Cited by 63
Pharmacokinetics and Pharmacodynamics of CHF5074 After Short-term Administration in Healthy SubjectsBruno P. Imbimbo, Magdy Shenouda, E. Frigerio et al.|Alzheimer Disease & Associated Disorders|2012Cited by 37
Effects of Topical Application of CHF6467, a Mutated Form of Human Nerve Growth Factor, on Skin Wound Healing in Diabetic MiceAlessandro Giuliani, Laura Calzà, Luca Lorenzini et al.|Journal of Pharmacology and Experimental Therapeutics|2020Cited by 13
AnnouncementDenis Becquet, Anders Lindahl, Anne‐Marie François‐Bellan et al.|Neuroendocrinology|2008Cited by 4